AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
2.580
+0.010 (0.39%)
Sep 10, 2025, 10:48 AM - Market open
AIM ImmunoTech Market Cap
AIM ImmunoTech has a market cap or net worth of $6.83 million as of September 10, 2025. Its market cap has decreased by -77.97% in one year.
Market Cap
6.83M
Enterprise Value
8.80M
1-Year Change
-77.97%
Ranking
n/a
Category
Stock Price
2.58
Market Cap Chart
Since January 29, 2018, AIM ImmunoTech's market cap has decreased from $17.94M to $6.83M, a decrease of -61.96%. That is a compound annual growth rate of -11.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 6.83M | -47.02% |
| Dec 31, 2024 | 12.88M | -39.50% |
| Dec 29, 2023 | 21.29M | -52.81% |
| Dec 28, 2021 | 45.12M | -51.57% |
| Dec 21, 2020 | 93.17M | 419.24% |
| Jan 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.85B |
| Johnson & Johnson | 426.18B |
| AbbVie | 371.72B |
| UnitedHealth Group | 315.10B |
| AstraZeneca | 251.31B |
| Novartis AG | 248.23B |
| Novo Nordisk | 236.38B |
| Abbott Laboratories | 229.65B |